VKTX: Viking Therapeutics Inc
今日VKTX汇率已更改-4.47%。当日,交易品种以低点28.04和高点29.81进行交易。
关注Viking Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
VKTX新闻
- Can Eli Lilly's 2026 Acquisition Spree Diversify Growth Beyond GLP-1s?
- LLY Rises 14% in a Month: Should You Hold as Obesity Growth Continues?
- GLP-1 Sales Forecast Jumps To $150 Billion By 2030
- Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
- Viking Therapeutics, Inc. (VKTX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
- Why Is Viking Therapeutics (VKTX) Up 3.2% Since Last Earnings Report?
- LLY Stock Gains 4% to All-Time High: Is Obesity Access the Catalyst?
- Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
- Can EU Label Expansions of NVO's GLP-1 Drugs Spur Sales Growth?
- LLY Reports Third Phase III Win for Next-Generation Obesity Drug
- Can Mounjaro, Zepbound & Foundayo Keep Fueling LLY's Growth Story?
- This Hot Weight-Loss Drug Stock May Have a Surprise Challenger
- Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly's Growing Pressure?
- Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead
- NVO Rallies 21% in a Month: How Should Investors Play the Stock?
- LLY Stock Pops 16% After Beat-and-Raise Q1: Buy, Hold or Take Profits?
- Lilly's Oral GLP-1 Pill Foundayo Starts Strong in Oral Obesity Market
- Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?
- Dozens of Experts Built This Simple Stock Screener for Traders & Investors. It Was Me.
- VKTX Q1 Earnings Miss on Higher Phase 3 Development Costs
- Viking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call Transcript
- Dow Jones Futures: Google, Amazon, Meta, Microsoft Are Big Earnings Movers After Oil Prices Spike, Fed's Powell Stays
- Can Oral Ozempic and Label Expansions Revive NVO's Near-Term Growth?
- Earnings This Week – April 27- May 1, 2026 - TipRanks.com
常见问题解答
VKTX股票今天的价格是多少?
Viking Therapeutics Inc股票今天的定价为28.45。它在28.04 - 29.81范围内交易,昨天的收盘价为29.78,交易量达到5921。VKTX的实时价格图表显示了这些更新。
Viking Therapeutics Inc股票是否支付股息?
Viking Therapeutics Inc目前的价值为28.45。股息政策取决于公司,而投资者也会关注7.97%和USD。实时查看图表以跟踪VKTX走势。
如何购买VKTX股票?
您可以以28.45的当前价格购买Viking Therapeutics Inc股票。订单通常设置在28.45或28.75附近,而5921和-3.66%显示市场活动。立即关注VKTX的实时图表更新。
如何投资VKTX股票?
投资Viking Therapeutics Inc需要考虑年度范围22.95 - 43.15和当前价格28.45。许多人在以28.45或28.75下订单之前,会比较-11.18%和。实时查看VKTX价格图表,了解每日变化。
Viking Therapeutics Inc股票的最高价格是多少?
在过去一年中,Viking Therapeutics Inc的最高价格是43.15。在22.95 - 43.15内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Viking Therapeutics Inc的绩效。
Viking Therapeutics Inc股票的最低价格是多少?
Viking Therapeutics Inc(VKTX)的最低价格为22.95。将其与当前的28.45和22.95 - 43.15进行比较,可以发现潜在的长期切入点。观看VKTX在图表上的实时走势以获取更多详细信息。
VKTX股票是什么时候拆分的?
Viking Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、29.78和7.97%中可见。
- 前一天收盘价
- 29.78
- 开盘价
- 29.53
- 卖价
- 28.45
- 买价
- 28.75
- 最低价
- 28.04
- 最高价
- 29.81
- 交易量
- 5.921 K
- 日变化
- -4.47%
- 月变化
- -11.18%
- 6个月变化
- -19.95%
- 年变化
- 7.97%
- 实际值
- 预测值
- 前值